18F-FDG PET in characterizing adrenal lesions detected on CT or MRI

Journal of Nuclear Medicine

Volumn 42, Issue 12, 2001, Pages 1795-1799

  Yun, M ^a   Kim, W ^a   Alnafisi, N ^a   Lacorte, L ^a   Jang, S ^a   Alavi, A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

18F FDG PET; Adrenal gland; Tumor

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADRENAL CORTEX ADENOMA; ADRENAL TUMOR; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR DIAGNOSIS; ADRENAL DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METASTASIS; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY;

ADRENAL GLAND DISEASES; ADRENAL GLAND NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUDEOXYGLUCOSE F 18; HUMAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035542957     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Adenomas of the adrenal cortex
2. The incidentally discovered adrenal mass
3. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes
4. Metastases in carcinoma: Analysis of 1000 autopsied cases
5. Indeterminate adrenal mass in patients with cancer: Evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose
6. 18F-fluorodeoxyglucose positron emission tomography
7. Imaging of adrenal tumors using FDG PET: Comparison of benign and malignant lesions
8. 137CS source
9. Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets-expectation maximization (OS-EM) reconstruction
10. Diagnosis and management of adrenal incidentalomas
11. Current concepts in imaging of adrenal masses
12. Imaging of incidentally discovered adrenal masses
13. Risk factors and long-term follow-up of adrenal incidentalomas
14. Can adrenal incidentalomas be safely observed?
15. Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma
16. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis
17. Delayed enhanced CT for differentiation of benign from malignant adrenal masses
18. Adrenal nonhyperfunctioning adenoma and nonadenoma: CT attenuation value as discriminative index
19. Incidentally discovered adrenal masses
20. Adrenal masses: Characterization with delayed contrast-enhanced CT
21. CT time-attenuation washout curves of adrenal adenomas and nonadenomas
22. Adrenal adenomas and nonadenomas: Assessment of washout at delayed contrast-enhanced CT
23. The incidental nonhyperfunctioning adrenal mass: An imaging algorithm for characterization
24. Benign adrenocortical masses: Diagnosis with chemical shift MR imaging
25. Adrenocortical carcinoma: MR imaging appearance with current techniques
26. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases
27. Pheochromocytomas: Imaging with 2-[fluorine-18] fluoro-2-deoxy-D-glucose PET
28. Evaluation of primary pulmonary carcinoid tumors using FDG PET